Abstract

BackgroundHLA-E is a non-classical HLA molecule that can engage the heteromeric inhibitory receptor NKG2A/CD94 to suppress T-cell/NK-cells. Blockade of NKG2A in combination with other immunostimulatory antibodies shows encouraging clinical activity...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call